Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2011
11/17/2011WO2011140639A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion
11/17/2011WO2011090684A3 Methods for developing endothelial cells from pluripotent cells and endothelial cells derived
11/17/2011WO2011089170A3 Process for preparing fgf-21 with low degree of o-glycosylation
11/17/2011WO2011084647A3 Toxin-immunity system
11/17/2011WO2011084324A3 Novel bacillus thuringiensis gene with lepidopteran activity
11/17/2011WO2011081366A3 Beef-specific age determination marker containing the p21 protein
11/17/2011WO2011077133A3 Method of treatment and screening method
11/17/2011WO2010139469A8 Antibodies against human ccn1 and uses thereof
11/17/2011WO2010136562A3 Moraxella catarrhalis antigens
11/17/2011WO2010109053A8 Methods and compositions for the treatment of cirrhosis and liver fibrosis
11/17/2011US20110283426 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
11/17/2011US20110283417 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor
11/17/2011US20110283414 Soybean Cultivar 95092896
11/17/2011US20110283413 Soybean Cultivar 99497033
11/17/2011US20110283412 Plants and seeds of hybrid corn variety ch812985
11/17/2011US20110283401 Soybean Cultivar S090243
11/17/2011US20110283400 Soybean cultivar 92394228
11/17/2011US20110283399 Soybean cultivar 98433118
11/17/2011US20110283398 Soybean cultivar 96462908
11/17/2011US20110283397 Plants and seeds of hybrid corn variety ch396198
11/17/2011US20110283396 Plants and seeds of hybrid corn variety ch957322
11/17/2011US20110283395 Plants and seeds of hybrid corn variety ch434101
11/17/2011US20110283394 Plants and seeds of hybrid corn variety ch918848
11/17/2011US20110283393 Soybean cultivar s090253
11/17/2011US20110283392 Soybean cultivar 97274007
11/17/2011US20110283391 Soybean Cultivar 90362556
11/17/2011US20110283390 Soybean Cultivar 96292716
11/17/2011US20110283389 Soybean Cultivar 99466158
11/17/2011US20110283388 Soybean Cultivar 93397033
11/17/2011US20110283387 Soybean Cultivar 90202016
11/17/2011US20110283386 Soybean Cultivar S090250
11/17/2011US20110283385 Plants and seeds of corn variety cv032267
11/17/2011US20110283382 Plants and seeds of corn variety cv556014
11/17/2011US20110283381 Plants and seeds of corn variety cv353100
11/17/2011US20110283380 Plants and seeds of corn variety cv502609
11/17/2011US20110283379 Plants and seeds of corn variety cv385683
11/17/2011US20110282032 Process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn)
11/17/2011US20110282031 A1 adenosine receptor diagnostic probes
11/17/2011US20110282030 Naturiuretic polypeptides
11/17/2011US20110282029 Novel peptides that bind to the erythropoietin receptor
11/17/2011US20110281939 Polynucleotide aptamer-based cross-linked materials and uses thereof
11/17/2011US20110281856 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
11/17/2011US20110281803 Sulfatase enzymes
11/17/2011US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011US20110281797 Site-specific monoconjugated insulinotropic glp-1 peptides
11/17/2011US20110281796 Novel activin receptor and uses thereof
11/17/2011US20110281792 Binding-site modified lectins and uses thereof
11/17/2011US20110281791 Crystalline insulin-conjugates
11/17/2011US20110281789 Ulbp antibodies
11/17/2011US20110281786 Stem cell expansion enhancing factor and method of use
11/17/2011US20110281767 Compositions and methods for molecular biology
11/17/2011US20110281349 Insect Desiccation Resistance Genes and Uses Thereof
11/17/2011US20110281302 Compositions and methods of treating disease with fgfr fusion proteins
11/17/2011US20110281299 Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
11/17/2011US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011US20110281284 Novel liver cancer marker
11/17/2011US20110281258 Human Immunodeficiency Virus And Uses Thereof
11/17/2011US20110280948 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
11/17/2011US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011US20110280902 Compounds and methods for diagnosis and treatment of leishmaniasis
11/17/2011US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease
11/17/2011US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
11/17/2011US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes
11/17/2011US20110280897 Polypeptides and uses thereof
11/17/2011US20110280894 Her2/neu specific t cell receptors
11/17/2011US20110280889 High affinity t cell receptor and use thereof
11/17/2011US20110280885 Cancer immunotherapy
11/17/2011US20110280882 Leukolectins and uses thereof
11/17/2011US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011US20110280863 Methods and compositions for the detection and treatment of preeclampsia
11/17/2011US20110280856 Treatment of alpha-galactosidase a deficiency
11/17/2011US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation
11/17/2011US20110280830 Albumin Fusion Proteins
11/17/2011US20110280826 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof
11/17/2011US20110280806 Dye conjugate imaging agents
11/17/2011US20110280802 Linkers For Radiopharmaceutical Compounds
11/17/2011CA2800610A1 Differentiation of human embryonic stem cells
11/17/2011CA2799470A1 Humanized ttc and methods of use thereof
11/17/2011CA2799192A1 Improved complement receptor 2 (cr2) targeting groups
11/17/2011CA2799181A1 Ospa chimeras and use thereof in vaccines
11/17/2011CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use
11/17/2011CA2799095A1 Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
11/17/2011CA2798905A1 Growth promoting fusion proteins
11/17/2011CA2792314A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion
11/17/2011CA2784666A1 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
11/16/2011EP2386859A2 Diagnostic tumor markers
11/16/2011EP2386639A2 Modified pore-forming protein toxins and use thereof
11/16/2011EP2386635A2 Mutant G-protein coupled receptors (GPCR) and methods for selecting them
11/16/2011EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011EP2386573A1 Transgenic animal with enhanced immune response and method for the preparation thereof
11/16/2011EP2386572A1 Insulin derivative
11/16/2011EP2386571A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/16/2011EP2386570A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/16/2011EP2386569A1 Alpha-amylase mutants
11/16/2011EP2386568A1 Alpha-amylase mutants